ID
13394
Description
Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00712686
Link
https://clinicaltrials.gov/show/NCT00712686
Keywords
Versions (1)
- 2/10/16 2/10/16 -
Uploaded on
February 10, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Schizophrenia NCT00712686
Eligibility Schizophrenia NCT00712686
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
schizoaffective disorder
Data type
boolean
Alias
- UMLS CUI [1]
- C0036337
Description
mental disorders
Data type
boolean
Alias
- UMLS CUI [1]
- C0004936
Description
olanzapine response
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0171023
- UMLS CUI [1,2]
- C1704632
Description
therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0087111
Description
substance abuse
Data type
boolean
Alias
- UMLS CUI [1]
- C0038586
Description
hypersensitivity
Data type
boolean
Alias
- UMLS CUI [1]
- C0020517
Description
suicidal
Data type
boolean
Alias
- UMLS CUI [1]
- C0438696
Description
thyroid disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0040128
Description
comorbidity
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
health status
Data type
boolean
Alias
- UMLS CUI [1]
- C0018759
Similar models
Eligibility Schizophrenia NCT00712686
- StudyEvent: Eligibility
C0277556 (UMLS CUI [1,2])
C1704632 (UMLS CUI [1,2])